The two faces of Rift Valley fever virus virulence factor NSs: The development of a vaccine and the elucidation of pathogenesis

References

• Daubney R, Hudson JR. Enzootic hepatitis or Rift Valley fever: An undescribed virus disease of sheep cattle and man from east Africa. J Path Bact 1931; 34:545-579; http://dx.doi.org/10.1002/path.1700340418
   Google Scholar
• Ikegami T. Molecular biology and genetic diversity of Rift Valley fever virus. Antiviral Res 2012; 95(3):293-310; PMID:22710362; http://dx.doi.org/10.1016/j.antiviral.2012.06.001
   PubMed Web of Science ®Google Scholar
• Rolin AI, Berrang-Ford L, Kulkarni MA. The risk of Rift Valley fever virus introduction and establishment in the United States and European Union. Emerg Microbes Infect 2013; 2(12):e81; PMID:26038446; http://dx.doi.org/10.1038/emi.2013.81
   PubMedGoogle Scholar
• Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J. Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 2010; 41(6):61; PMID:21188836; http://dx.doi.org/10.1051/vetres/2010033
   PubMed Web of Science ®Google Scholar
• Ikegami T, Makino S. The pathogenesis of Rift Valley Fever. Viruses 2011; 3(5):493-519; PMID:21666766; http://dx.doi.org/10.3390/v3050493
   PubMed Web of Science ®Google Scholar
• Linthicum KJ, Britch SC, Anyamba A. Rift Valley fever: An emerging mosquito-borne disease. Annu Rev Entomol 2016; 61:395-415; PMID:26982443; http://dx.doi.org/10.1146/annurev-ento-010715-023819
   PubMed Web of Science ®Google Scholar
• Bird BH, Nichol ST. Breaking the chain: Rift Valley fever virus control via livestock vaccination. Curr Opin Virol 2012; 2(3):315-323; PMID:22463980; http://dx.doi.org/10.1016/j.coviro.2012.02.017
   PubMed Web of Science ®Google Scholar
• Bird BH, Ksiazek TG, Nichol ST, Maclachlan NJ. Rift Valley fever virus. J Am Vet Med Assoc 2009; 234(7):883-893; PMID:19335238; http://dx.doi.org/10.2460/javma.234.7.883
   PubMed Web of Science ®Google Scholar
• Indran SV, Ikegami T. Novel approaches to develop Rift Valley fever vaccines. Front Cell Infect Microbiol 2012; 2:131; PMID:23112960; http://dx.doi.org/10.3389/fcimb.2012.00131
   PubMed Web of Science ®Google Scholar
• McElroy AK, Albarino CG, Nichol ST. Development of a RVFV ELISA that can distinguish infected from vaccinated animals. Virol J 2009; 6:125; PMID:19678951; http://dx.doi.org/10.1186/1743-422X-6-125
   PubMed Web of Science ®Google Scholar
• Miller MM, Bennett KE, Drolet BS, Lindsay R, Mecham JO, Reeves WK, Weingartl HM, Wilson WC. Evaluation of the efficacy, potential for vector transmission, and duration of immunity of MP-12, an attenuated Rift Valley fever virus vaccine candidate, in sheep. Clin Vaccine Immunol 2015; 22:930-937; PMID:26041042; http://dx.doi.org/10.1128/CVI.00114-15
   PubMed Web of Science ®Google Scholar
• Bird BH, Maartens LH, Campbell S, Erasmus BJ, Erickson BR, Dodd KA, Spiropoulou CF, Cannon D, Drew CP, Knust B, McElroy AK, Khristova ML, Albarino CG, Nichol ST. Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep. J Virol 2011; 85(24):12901-12909; PMID:21976656; http://dx.doi.org/10.1128/JVI.06046-11
   PubMed Web of Science ®Google Scholar
• Nishiyama S, Slack OA, Lokugamage N, Hill TE, Juelich TL, Zhang L, Smith JK, Perez D, Gong B, Freiberg AN, Ikegami T. Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR. Virulence 2016; 7(8):871-881; PMID:27248570; http://dx.doi.org/10.1080/21505594.2016.1195528
   PubMedGoogle Scholar
• Caplen H, Peters CJ, Bishop DH. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol 1985; 66:2271-2277; PMID:4045430; http://dx.doi.org/10.1099/0022-1317-66-10-2271
   PubMed Web of Science ®Google Scholar
• Ikegami T, Hill TE, Smith JK, Zhang L, Juelich TL, Gong B, Slack OA, Ly HJ, Lokugamage N, Freiberg AN. Rift Valley fever virus MP-12 vaccine is fully attenuated by a combination of partial attenuations in the S, M, and Lsegments. J Virol 2015; 89(14):7262-7276; PMID:25948740; http://dx.doi.org/10.1128/JVI.00135-15
   PubMed Web of Science ®Google Scholar
• Ikegami T, Won S, Peters CJ, Makino S. Rescue of infectious Rift Valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol 2006; 80(6):2933-2940; PMID:16501102; http://dx.doi.org/10.1128/JVI.80.6.2933-2940.2006
   PubMed Web of Science ®Google Scholar
• Lee NH, Lee JA, Park SY, Song CS, Choi IS, Lee JB. A review of vaccine development and research for industry animals in Korea. Clin Exp Vaccine Res 2012; 1(1):18-34; PMID:23596575; http://dx.doi.org/10.7774/cevr.2012.1.1.18
   PubMedGoogle Scholar
• Phoenix I, Lokugamege N, Nishiyama S, Ikegami T. Mutational analysis of the Rift Valley fever virus glycoprotein precursor proteins for Gn protein expression. Viruses 2016; 8(6):151; http://dx.doi.org/10.3390/v8060151
   Web of Science ®Google Scholar
• Le May N, Dubaele S, Proietti De Santis L, Billecocq A, Bouloy M, Egly JM. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 2004; 116(4):541-550; PMID:14980221; http://dx.doi.org/10.1016/S0092-8674(04)00132-1
   PubMed Web of Science ®Google Scholar
• Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, Bouloy M, Haller O. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 2004; 78(18):9798-9806; PMID:15331713; http://dx.doi.org/10.1128/JVI.78.18.9798-9806.2004
   PubMed Web of Science ®Google Scholar
• Habjan M, Pichlmair A, Elliott RM. NSs protein of Rift Valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol 2009; 83(9):4365-4375; PMID:19211744; http://dx.doi.org/10.1128/JVI.02148-08
   PubMed Web of Science ®Google Scholar
• Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, Makino S. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog 2009; 5(2):e1000287; PMID:19197350; http://dx.doi.org/10.1371/journal.ppat.1000287
   PubMed Web of Science ®Google Scholar
• Lihoradova O, Kalveram B, Indran SV, Lokugamage N, Juelich TL, Hill TE, Tseng CT, Gong B, Fukushi S, Morikawa S, et al. The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12. J Virol 2012; 86(14):7650-7661; PMID:22573861; http://dx.doi.org/10.1128/JVI.00778-12
   PubMed Web of Science ®Google Scholar
• Indran SV, Lihoradova OA, Phoenix I, Lokugamage N, Kalveram B, Head JA, Tigabu B, Smith JK, Zhang L, Juelich TL, et al. Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice. J Gen Virol 2013; 94(Pt 7):1441-1450; PMID:23515022; http://dx.doi.org/10.1099/vir.0.051250-0
   PubMed Web of Science ®Google Scholar
• Lihoradova OA, Indran SV, Kalveram B, Lokugamage N, Head JA, Gong B, Tigabu B, Juelich TL, Freiberg AN, Ikegami T. Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus. PLoS Negl Trop Dis 2013; 7(4):e2181; PMID:23638202; http://dx.doi.org/10.1371/journal.pntd.0002181
   PubMed Web of Science ®Google Scholar
• Morrill JC, Laughlin RC, Lokugamage N, Pugh R, Sbrana E, Weise WJ, Adams LG, Makino S, Peters CJ. Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep. Vaccine 2013; 31(3):559-565; PMID:23153443; http://dx.doi.org/10.1016/j.vaccine.2012.10.118
   PubMed Web of Science ®Google Scholar
• Xu F, Liu D, Nunes MR, DA Rosa AP, Tesh RB, Xio SY. Antigenic and genetic relationships among Rift Valley fever virus and other selected members of the genus Phlebovirus (Bunyaviridae). Am J Trop Med Hyg 2007; 76(6):1194-1200; PMID:17556635
   PubMed Web of Science ®Google Scholar
• Gori Savellini G, Weber F, Terrosi C, Habjan M, Martorelli B, Cusi MG. Toscana virus induces interferon although its NSs protein reveals antagonistic activity. J Gen Virol 2011; 92:71-79; PMID:20861320; http://dx.doi.org/10.1099/vir.0.025999-0
   PubMed Web of Science ®Google Scholar
• Perrone LA, Narayanan K, Worthy M, Peters CJ. The S segment of Punta Toro virus (Bunyaviridae, Phlebovirus) is a major determinant of lethality in the Syrian hamster and codes for a type I interferon antagonist. J Virol 2007; 81(2):884-892; PMID:17050607; http://dx.doi.org/10.1128/JVI.01074-06
   PubMed Web of Science ®Google Scholar
• Bird BH, Albarino CG, Hartman AL, Erickson BR, Ksiazek TG, Nichol ST. Rift Valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals. J Virol 2008; 82(6):2681-2691; PMID:18199647; http://dx.doi.org/10.1128/JVI.02501-07
   PubMed Web of Science ®Google Scholar